Development of Zingiber officinale in oral dissolving films: Effect of polymers on in vitro, in vivo parameters and clinical efficacy

Main Article Content

Anwar S Daud
Nidhi P Sapkal
Minal N Bonde


Oral dissolving drug delivery system offers a solution for those patients having difficulty in swallowing tablets/capsules,etc. Zingiber officinale, has been used for medicinal purpose since antiquity to treat motion sickness, pregnancy, and
cancer-chemotherapy-induced vomiting, mild stomach upset, cough, chronic bronchial problems, and low-grade infections of all kinds and anorexia condition. This work investigates the possibility of developing Zingiber officinale oral dissolving films allowing fast, reproducible dissolution in oral cavity; thus bypassing first pass metabolism. The oral dissolving films were prepared by solvent-casting method. Prepared films were evaluated for film-forming properties, physico-mechanical properties, palatability, microbial limit test, accelerated stability studies, and clinical efficacy test. The different polymers
such as hydroxypropyl methylcellulose 5cps, maltodextrin, pullulan, and polyvinyl alcohol were explored individually and in combination with each other for the formation of film. Among all polymers, maltodextrin and HPMC 5 cps alone and
in combination showed excellent film-forming properties as well as very good physico-mechanical properties. The films resulted into excellent palatability along with least disintegrating time. But at accelerated stability studies, only HPMC 5
cps was found to be stable when compared with other formulations. So, it was concluded that HPMC 5 cps is the best film forming as well as stable polymer with respect to Zingiber officinale oral dissolving film.


Download data is not yet available.

Article Details

How to Cite
Daud, A. S., Sapkal, N. P., & Bonde, M. N. (2014). Development of Zingiber officinale in oral dissolving films: Effect of polymers on in vitro, in vivo parameters and clinical efficacy. Asian Journal of Pharmaceutics (AJP), 5(3).


Grigoli MD. Dosage forms obtained by film coating: from transdermal

to oral forms. Available from:

Italy/pdfs/2010SimposioDiGrigoli.pdf. [Last accessed on 2010 May 5].

Shukla D, Chakraborty S, Singh S, Mishra B. Mouth Dissolving Tablets

I: An Overview of Formulation Technology. Sci Pharm 2009;77:309-26.

Huang QR, Iwamoto M, Aoki S, Tanaka N, Tajima K, Yamahara J, et al.

Anti-5-hydroxytryptamine3 effect of galanolactone, diterpenoid

isolated from ginger. Chem Pharm Bull (Tokyo) 1991;39:397-9.

Yamahara J, Rong HQ, Iwamoto M, Kobayashi G, Matsuda H. Fujimura

H. Active components of ginger exhibiting antiserotonergic action.

Phytother Res 1989;3:70-1.

Pillai AK, Sharma KK, Gupta YK, Bakhshi S. Anti-emetic effect of ginger

powder versus placebo as an add-on therapy in children and young

adults receiving high emetogenic chemotherapy. Pediatr Blood Cancer


Qian QH, Yue W, Chen WH, Yang ZH, Liu ZT, Wang YX. Effect of gingerol

on substance P and NK1 receptor expression in a vomiting model of

mink. Chin Med J (Engl) 2010;123:478-84.

Wu KL, Rayner CK, Chuah SK, Changchien CS, Lu SN, Chiu YC, et al.

Effects of ginger on gastric emptying and motility in healthy humans.

Eur J Gastroenterol Hepatol 2008;20:436-40.

Devi VA, Jain N, Valli KS. Importance of novel drug delivery systems

in herbal medicines. Pharmacog Rev 2010;4:27-31.

Dixit RP, Puthli SP. Oral strip technology: Overview and future potential.

J Control Release 2009;139:94-107.

Patel R, Naik S, Patel J, Baria A. Formulation development and

evaluation of mouth melting films of ondensetron. Arch Pharm Sci

Res 2009;1:212-17.

Tingstad JE. Physical stability testing of pharmaceuticals. J Pharm Sci


Dzija M, Barkalow D, Chapdelaine A, Zyck D. Edible film formulations

containing maltodextrin. US PATENT 2003/0035841. 2003.

Shinde AJ, Garala KC, More HN. Development and characterization of

transdermal therapeutics system of tramadol hydrochloride. Asian J

Pharm 2008;4:265-69.